Reuters logo
BRIEF-Neuren Pharmaceuticals ‍announces grant of two new patents for Trofinetide to 2032​
May 31, 2017 / 5:23 AM / 6 months ago

BRIEF-Neuren Pharmaceuticals ‍announces grant of two new patents for Trofinetide to 2032​

May 31 (Reuters) - Neuren Pharmaceuticals Ltd

* ‍announces grant of two new patents for Trofinetide to 2032​

* Says granted of two new patents in United States and Europe concerning use of Trofinetide to treat autism spectrum disorders​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below